<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        14-5286-19
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        SILOMES 100 mg Tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMISULPRIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        60.9
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="UNITED PHARMACEUTICAL COMPANY" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            UNITED PHARMACEUTICAL COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            MS Pharma Saudi (MSPS)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N05AL05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Tablets contain amisulpride and belongs to a group of medicines called antipsychotics which help to control the symptoms of a mental illness called schizophrenia.</p><p>Symptoms include:<br />&bull;delusions (having strange or unusual thoughts)<br />&bull;hallucinations (seeing or hearing things that are not there)<br />&bull;being suspicious or aggressive for no apparent reason (these are so called &ldquo;positive symptoms&rdquo;)<br />&bull;becoming withdrawn and subdued (these are so called &ldquo;negative symptoms&rdquo;).</p><p>Silomes can be used at the start of and for the long term treatment of schizophrenia</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>a. Do not take Silomes</strong><br />Never take Silomes in the following situations:<br />&bull;If you have a pheochromocytoma (growth of the adrenal medullary gland secreting substances that induce sever hypertension),<br />&bull;Children under 15 years of age,<br />&bull;Breast-feeding.<br />&bull;Known allergy to Amisulpride or to any of the other ingredients,<br />&bull;Known prolactin-dependent tumor<br />&bull;In combination with levodopa (medicine used for Parkinson&rsquo;s disease)<br />If you are unsure of anything, it is essential that you ask your doctor or pharmacist for advice.</p><p><strong>b. Take special care with Silomes</strong><br />Talk to your doctor or pharmacist before taking your medicine if:<br />&bull;you have kidney problems<br />&bull;you have Parkinson&rsquo;s disease<br />&bull;you have ever had fits (epileptic seizures)<br />&bull;you are diabetic or have been told you have an increased risk of developing diabetes<br />&bull;you have an unusual heart rate (rhythm)<br />&bull;you have heart disease or family history of heart problems or sudden death<br />&bull;you have a long QT interval or a history of this in the family (this is a measure of the way your heart is working and can be detected by a doctor using an electrocardiogram)<br />&bull;you had a stroke previously or your doctor has told you that you are at risk of a stroke<br />&bull;you or someone else in your family has a history of blood clots, as medicines like these have been associated with formation of blood clots<br />&bull;you or someone else in your family has a history of breast cancer, as amisulpride can affect the risk of developing breast cancer. You should therefore be closely monitored during treatment with Amisulpride<br />&bull;you have a slow heart beat (less than 55 beats per minute)<br />&bull;you are taking other medicines that could affect your heart&rsquo;s function: check with your doctor before taking any other medicine. See also<br />the following section.<br />&bull;you have been told you have a low amount of potassium or magnesium in your blood.<br />&bull;you are elderly. This is because elderly people are more likely to get low blood pressure or feel sleepy. A small increase in the number of deaths of elderly people with dementia has been reported in patients taking antipsychotics compared to those not receiving antipsychotics.</p><p>If you are unsure of anything, do not hesitate to ask your doctor or pharmacist for advice.</p><p><strong>c. Taking other medicines, herbal or dietary</strong><br />supplements<br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines including medicines obtained without a prescription.<br />This is because amisulpride can affect the way some other medicines work. Also some medicines can affect the way amisulpride works. In particular, do not take this medicine and tell your doctor if you are taking:<br />&bull;bromocriptine or ropinirole (medicines used to treat Parkinson&rsquo;s disease)<br />&bull;levodopa, a medicine to treat Parkinson&rsquo;s disease<br />&bull;medicines to treat heart rhythm problems (such as quinidine, disopyramide, procainamide, amiodarone, sotalol)<br />&bull;cisapride (used to treat stomach problems)<br />&bull;bepridil (used to treat angina/chest pain and changes in heart rhythm)<br />&bull;sultopride and thioridazine (for schizophrenia)</p><p>&bull;methadone (for pain and drug abuse)<br />&bull;halofantrine (to prevent malaria)<br />&bull;pentamidine (to treat infections in HIV patients)<br />&bull;erythromycin by injection or sparfloxacin (antibiotics)<br />&bull;medicines for fungal infections, such as clotrimazole<br />&bull;vincamine by injection (used for various brain disorders)</p><p>Tell your doctor if you are taking any of the following medicines:<br />&bull;medicines used to treat high blood pressure or other heart problems, that could slow your heart rate down. These include beta-blockers (such as nebivolol or bisoprolol, diltiazem, verapamil, clonidine, guanfacine, digoxin or digoxin-like medicines<br />&bull;medicines which can cause low potassium levels including diuretics (&ldquo;water tablets&rdquo;), some laxatives, amphotericin B (by injection), glucocorticoids (used for conditions such as asthma or rheumatoid arthritis) and tetracosactide (may be used in clinical investigations)<br />&bull;medicines used to treat schizophrenia such as pimozide or haloperidol<br />&bull;imipramine or lithium (used to treat depression)<br />&bull;some antihistamines such as astemizole and terfenadine (for allergies)<br />&bull;other anti-psychotic medicines used for mental health problems<br />&bull;medicines for severe pain called opiates such as morphine or pethidine<br />&bull;medicines which help you sleep such as barbiturates and benzodiazepines<br />&bull;pain-killers such as tramadol and indomethacin<br />&bull;anaesthetics<br />&bull;antihistamines (for allergies) which make you sleepy, such as promethazine.</p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a<br />prescription.</p><p><br /><strong>d. Taking Silomes with Food and drinks</strong><br />Do not drink alcohol while you are taking this medicine. This is because it can increase the effects of alcohol.</p><p><strong>e. Pregnancy and lactation:</strong><br />Pregnancy:<br />Use of this medicine is not recommended during pregnancy. If you discover that you are pregnant, consult your doctor immediately, So that you may follow her recommendations regarding your treatment. Ask your doctor or pharmacist for advice before taking any medicine.</p><p>Lactation:<br />You must not breast-feed if you are taking this medicinal product Ask your doctor or pharmacist for advice before taking any medicine.</p><p><strong>f. Effects on ability to drive and use machines:</strong><br />Be aware, especially if you drive or use machines of the risk of Drowsiness associated with the use of this medicine.</p><p><strong>g. Important information about some of the ingredients of Silomes</strong><br />This medicine contains lactose. You should not use this medicine if you have galactose intolerance, Lapp lactase deficiency or glucose and galactose malabsorption syndrome (rare hereditary diseases).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take your medicine exactly as your doctor has told you. This will help you to get the best results and lower the risk of side effects.<br />You should check with your doctor or pharmacist if you are not sure.</p><p><strong>Method and route of administration: </strong>Oral use.</p><p><strong>For acute psychotic episodes:</strong><br />Oral doses between 400 mg/day and 800 mg/ day are recommended. In individual cases, the daily dose may be increased up to 1200 mg/ day. Doses above 1200 mg/day have not been extensively evaluated for safety and therefore should not be used. No specific titration is required when initiating the treatment with Silomes. Doses should be adjusted according to individual response. For patients with mixed positive and negative symptoms:<br />Doses should be adjusted to obtain optimal control of positive symptoms.</p><p><strong>Maintenance treatment:</strong><br />Should be established individually with the minimally effective dose. For patients characterised by predominant negative symptoms, oral doses between 50 mg/day and 300 mg/day are recommended.<br />Doses should be adjusted individually.</p><p>Silomes can be administered once daily at oral doses up to 300 mg, higher doses should be administered bid. The minimum effective dose should be used.</p><p><strong>Elderly:</strong><br />Amisulpride should be used with particular caution because of a possible risk of hypotension and sedation. Reduction in dosage may also be required because of renal insufficiency.</p><p><strong>Children:</strong><br />The efficacy and safety of amisulpride from puberty to the age of 18 years have not been established. There are limited data available on the use of amisulpride in adolescents in schizophrenia.<br />Therefore, the use of amisulpride from puberty to the age of 18 years is not recommended;</p><p>in children up to puberty amisulpride is contraindicated, as its safety has not yet been established.</p><p><strong>Renal insufficiency:</strong><br />Silomes is eliminated by the renal route. In renal insufficiency, the dose should be reduced to half in patients with creatinine clearance (CRCL) between 30-60 ml/min and to a third in patients with CRCL between 10-30 ml/min. As there is no experience in patients with severe renal impairment (CRCL &lt; 10 ml/min) particular care is recommended in these patients.</p><p><strong>Hepatic insufficiency: </strong></p><p>since the drug is weakly metabolised a dosage reduction should not be necessary.</p><p>Duration of treatment: In all cases, strictly follow your doctor&rsquo;s prescription. Do not stop the treatment of your own accord.</p><p><strong>a.If you take more Silomes than you should</strong><br />Contact your doctor or hospital immediately.<br />Take the tablets, leaflet and/or carton with you so the doctor knows what you have taken. The following effects may happen: feeling restless or<br />shaky, rigid muscles, low blood pressure, feeling drowsy or sleepy which could lead to a loss of consciousness.</p><p><strong>b.If you forget to take Silomes Tablets:</strong><br />Take the next dose at the usual time. Do not take a double dose. If you have forgotten several doses, consult your doctor.<br />&nbsp;</p><p><strong>c.If you stop taking Silomes Tablets</strong><br />In all cases, strictly follow your doctor&rsquo;s prescription. Do not stop the treatment of your own accord.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines. Silomes can cause side effects, although not everybody gets them. Stop taking Amisulpride and see a doctor or go to a hospital immediately if you notice any of the following side effects:</p><p><strong>Uncommon (may affect up to 1 in 100 people)</strong><br />&bull;A serious allergic reaction. The signs may include an itchy, lumpy rash, difficulty swallowing or breathing, swelling of your lips, face, throat or tongue<br />&middot; A fit (seizure)</p><p><strong>Not known (frequency cannot be estimated from the available data)</strong><br />&bull;High temperature, sweating, stiff muscles, fast heartbeat, fast breathing and feel confused, drowsy or agitated. These could be the symptoms of a serious but rare side effect called &lsquo;neuroleptic malignant syndrome&rsquo;<br />&bull;An unusual heart rate, very fast heart rate or chest pain which could result in a heart attack or life-threatening heart disorder.<br />&bull;Blood clots in the veins especially in the legs (symptoms include swelling, pain and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing. If you notice any of these signs, seek medical advice immediately.<br />&bull;You get more infections than usual, causing fever, sore throat or mouth ulcers. This could be because of a decrease in the number, or lack of white blood cells.<br />&bull;Benign (non-cancerous) pituitary tumour such as prolactinoma.<br />&bull;Feeling unwell, confused or weak, feeling sick (nausea), loss of appetite, feeling irritable. This could be signs of an illness called syndrome of inappropriate antidiuretic hormone secretion (SIADH).</p><p>Tell your doctor as soon as possible if you have any of the following side effects:<br /><strong>Very common (may affect more than 1 in 10 people)</strong><br />&bull;Trembling, muscle stiffness or spasm, slow movement, producing more saliva than usual or feeling restless.<br /><strong>Common (may affect up to 1 in 10 people)</strong><br />&middot; Movements that you cannot control, mainly of the head, neck, jaw or eyes.</p><p><strong>Uncommon (may affect up to 1 in 100 people)</strong><br />&middot; Movements that you cannot control, mainly of the face or tongue</p><p><strong>Other side effects include:<br />Common (may affect up to 1 in 10 people)</strong><br />&bull;Difficulty sleeping (insomnia) or feeling anxious or agitated<br />&bull;Feeling drowsy or sleepy<br />&bull;Constipation, feeling or being sick, dry mouth<br />&bull;Putting on weight<br />&bull;Low blood pressure, which may cause you to feel dizzy<br />&bull;Increased blood levels of prolactin (a protein), which would be seen in a test and may cause:<br />- Breast pain or enlargement, unusual production of breast milk (these can occur in women and men)<br />- Menstrual problems such as missed periods<br />- Sexual effects such as problems reaching orgasm or difficulty in getting or maintaining an erection<br />- Unusual growth in the pituitary gland</p><p><strong>Uncommon (may affect up to 1 in 100 people)</strong><br />&bull;Slowing of the heart beat<br />&bull;High blood sugar (hyperglycaemia)<br />&bull;Increase in liver enzymes, which would be seen in a blood test</p><p><strong>Rare (may affect up to 1 in 1,000 people)</strong><br />&bull;Withdrawal symptoms after stopping treatment of high doses of amisulpride. These may include feeling or being sick difficulty sleeping,<br />extreme restlessness, muscle stiffness or abnormal movements, or your original illness may come back.</p><p><strong>Not known (frequency cannot be estimated&nbsp;from the available data)</strong><br />&bull;Withdrawal symptoms seen in newborn babies where the mother has taken this medicine.<br />&bull;Raised levels of certain fats (triglycerides) and cholesterol in the blood<br />&bull;Confusion<br />&bull;Low levels of sodium in your blood which may be seen in blood tests (hyponatraemia).</p><p>If you notice any side effects not mentioned in this leaflet, or if any of the side effects gets serious.</p><p>Please inform your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-Keep this medicine out of the sight and reach of children.<br />-Do not store above 30&deg;C.<br />-Do not use Silomes Tablets after the expiry&nbsp;date which is stated on the carton and blister after &lsquo;EXP&rsquo;. The expiry date refers to the last<br />day of that month.<br />-Do not use Silomes Tablets if you notice description of the visible signs of deterioration.<br />-Do not throw away any medicines via wastewater or household waste.</p><p>Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is: Amisulpride.<br />Silomes 50mg Tablets: Each tablet contains 50 mg Amisulpride.<br />Silomes 100mg Tablets: Each tablet contains 100 mg Amisulpride.</p><p>Silomes 200mg Tablets: Each tablet contains 200 mg Amisulpride.<br />Silomes 400mg Tablets: Each tablet contains 400 mg Amisulpride.</p><p>Excipients:<br />Lactose, Sodium Starch Glycolate, Hydroxypropyl Methyl Cellulose, Microcrystalline Cellulose, Magnesium Stearate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Pharmaceutical form: Tablets
Silomes 50mg Tablets: White round convex tablet embossed with “U1” from one side and plain from the other side
Silomes 100mg Tablets: White round convex tablet embossed with “U2’ from one side and plain from the other side.
Silomes 200mg Tablets: White round convex tablet embossed with “U3” from one side and plain from the other side.
Silomes 400mg Tablets: White caplet shaped tablet embossed with “U7” from one side and plain from the other side.

Silomes Tablets are packed in PVC/PVDC/ Aluminum foil blister, in carton box with a folded leaflet, in pack size of 30 Tablets.

Hospital packs are also available.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>MS Pharma Saudi</p><p>Riyadh, Kingdome Saudi Arabia.<br />info-ksa@mspharma.com</p><p><br />Manufacturer by<br />United Pharmaceutical Mfg. Co. Ltd. - Jordan for MS Pharma-Saudi.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Feb/2020; version number: SPM190330
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>أقراص&nbsp; سايلومس تحتوي علي أميسولبريد وينتمي إلى مجموعه من الادويه تسمي مضادات الذهان التي تساعد علي السيطرة علي اعراض مرض عقلي يسمي الفصام.</p><p>وتشمل الاعراض:</p><p>&bull; الأوهام (وجود أفكار غريبه أو غير عادية)</p><p>&bull; الهلوسة (رؤية أو سماع الأشياء التي ليست هناك)</p><p>&bull; تصبح مشبوه أوعدواني من دون أي سبب واضح (هذه هي ما يسمي&nbsp; &laquo;الاعراض الايجابيه &raquo;)</p><p>&bull; أصبحت مسحوباً ومهزوماً (هذه هي ما يسمي&nbsp; &laquo;الاعراض السلبية &raquo;).</p><p>سايلومس يمكن استخدامها في بداية ولعلاج الفصام علي المدى الطويل.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>أ.لا تستعمل أقراص&nbsp; سايلومس</strong></p><p>لا تأخذ&nbsp; سايلومس مطلقًا في المواقف التالية:</p><p>-اذا كنت تعاني من ورم القواتم (نمو في الغدة النخاعية الكظرية التي تفرز مواد تسبب فرط حاد في ضغط الدم)</p><p>-الاطفال ما دون الخامسة عشر من العمر.</p><p>-المرأة المرضعة.</p><p>-اذا كنت تعاني من حساسية لمادة الأميسولبريد او لأي من السوغات.</p><p>-اذا كنت مصاب بورم متعلق بالبرولاكتين.</p><p>-اذا كنت تتناول الليفودوبا (دواء يستعمل لعلاج مرض الباركنسون).</p><p>إذا لم تكن متأكدا من أي شيء، فمن الضروري أن تسأل طبيبك أو الصيدلي للحصول على المشورة.</p><p><strong>ب. الاحتياطات عند استعمال أقراص&nbsp; سايلومس&nbsp;</strong></p><p>تحدث إلى طبيبك أو الصيدلي قبل تناول الدواء إذا:</p><p>&bull; لديك مشاكل في الكلي</p><p>&bull; لديك مرض باركنسون</p><p>&bull; لديك من اي وقت مضي يناسب (نوبات الصرع)</p><p>&bull;كنت مصابا بالسكري أو قيل لك ان لديك زيادة خطر الاصابه بمرض السكري</p><p>&bull;لديك معدل ضربات القلب غير عادية (إيقاع)</p><p>&bull;لديك امراض القلب أو التاريخ العائلي من مشاكل في القلب أو الموت المفاجئ</p><p>&bull;لديك فتره QT طويلة أو تاريخ من هذا في الاسره (وهذا هو مقياس للطريقة التي يعمل بها قلبك ويمكن الكشف عنها من قبل طبيب باستخدام تخطيط كهربائي)</p><p>&bull;كنت قد السكتة الدماغية سابقا أو طبيبك قد قال لك ان كنت في خطر السكتة الدماغية</p><p>&bull;أنت أو شخص آخر في عائلتك لديه تاريخ من جلطات الدم ، والادويه مثل هذه ارتبطت بتشكيل جلطات الدم</p><p>&bull;أنت أو شخص آخر في عائلتك لديه تاريخ من سرطان الثدي ، كما يمكن ان يؤثر أميسولبريد علي خطر الاصابه بسرطان الثدي. ولذلك يجب ان تراقب عن كثب اثناء العلاج مع أميسولبريد</p><p>&bull;لديك ضربات القلب بطيئه (اقل من 55 نبضه في الدقيقة)</p><p>&bull;كنت تاخذ الادويه الأخرى التي يمكن ان تؤثر علي وظيفة قلبك: التحقق مع طبيبك قبل تناول اي دواء آخر. راجع أيضا المقطع التالي.</p><p>&bull;لقد قيل لك لديك كميه منخفضه من البوتاسيوم أو المغنيسيوم في الدم.</p><p>&bull; أنت مسن. وهذا لان المسنين هم أكثر عرضه للحصول علي انخفاض ضغط الدم أو يشعرون بالنعاس. وقد ابلغ عن زيادة طفيفه في عدد وفيات المسنين المصابين بالخرف في المرضي الذين يتناولون مضادات الذهان بالمقارنة مع تلك التي لا تلقي مضادات الذهان.</p><p><strong>ج. التداخلات الدوائية من تناول هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p>أخبر طبيبك أو الصيدلي إذا كنت تاخذ ، اتخذت مؤخرا أو قد تاخذ اي ادويه أخرى بما في ذلك الادويه التي تم الحصول عليها دون وصفه طبية.</p><p>وهذا لان أميسولبريد يمكن ان تؤثر علي الطريقة التي تعمل بعض الادويه الأخرى. أيضا بعض الادويه يمكن ان تؤثر علي الطريقة التي يعمل أميسولبريد.</p><p>علي وجه الخصوص ، لا تاخذ هذا الدواء وأخبر طبيبك إذا كنت تاخذ:</p><p>&bull;بروموكريبتين أو روبينيرول (الادويه المستخدمة لعلاج مرض باركنسون)</p><p>&bull;ليفودوبا ، دواء لعلاج مرض باركنسون</p><p>&bull;الادويه لعلاج مشاكل نظم القلب (مثل الكينيدين ، دايسوبرامايد ، بروكينامايد ، امييودارون ، سوتالول)</p><p>&bull;سيتابرايد (تستخدم لعلاج مشاكل في المعدة)</p><p>&bull;بيبريدل (تستخدم لعلاج الذبحة الصدرية/الم في الصدر والتغيرات في إيقاع القلب)</p><p>&bull;سولتوبرايد وثوريدازين (لمرض الفصام)</p><p>&bull;الميثادون (للألم وتعاطي المخدرات)</p><p>&bull;للوقاية من الملاريا) هالفوناترين)</p><p>&bull;بينتاميدين (لعلاج العدوى في مرضي فيروس نقص المناعة المصابين)</p><p>&bull;الاريثروميسين عن طريق الحقن أو سبارفلوكساسين (المضادات الحيوية)</p><p>&bull;الادويه للعدوى الفطرية ، مثل كلوتريمازولي</p><p>&bull; فينكامين عن طريق الحقن (المستخدمة لاضطرابات الدماغ المختلفة)</p><p><strong>أخبر طبيبك إذا كنت تتناول أيا من الادويه التالية:</strong></p><p>&bull; الادويه المستخدمة لعلاج ارتفاع ضغط الدم أو مشاكل القلب الأخرى ، التي يمكن ان تبطئ معدل ضربات القلب الخاص بك إلى أسفل. وتشمل هذه حاصرات بيتا (مثل نيبفولول أو بيسوبرولول ، ديلتيازيم ، فيراباميل ، كلونيدين ، جواينفاسين ، الديجوكسين أو الديجوكسين-مثل الادويه</p><p>&bull;الادويه التي يمكن ان تسبب انخفاض مستويات البوتاسيوم بما في ذلك مدرات البول ( &laquo;أقراص المياه &laquo;), بعض المسهلات, الامفوتيريسن B (عن طريق الحقن), السكرية (تستخدم لظروف مثل الربو أو التهاب المفاصل الروماتويدي) و تتراكوساكتيد (يمكن استخدامها في السريرية تحقيقات</p><p>&bull;الادويه المستخدمة لعلاج الفصام مثل بيموزيد أو هالوبيريدول</p><p>&bull;ايميبرامين أو الليثيوم (تستخدم لعلاج الاكتئاب)</p><p>&bull;بعض مضادات الهيستامين مثل استيميزول و تيرفينادين (للحساسية)</p><p>&bull; الادويه الأخرى المضادة للامراض الذهانية المستخدمة لمشاكل الصحة العقلية</p><p>&bull;ادويه للألم الشديد يسمي المواد الافيونيه مثل المورفين أو البيثيدين</p><p>&bull;الادويه التي تساعدك علي النوم مثل المهدئات و البنزوديازيبينات</p><p>&bull;الم-القتلة مثل ترامادول والاندوميثاسين</p><p>&bull;انجماليات</p><p>&bull;مضادات الهيستامين (للحساسية) التي تجعلك نعسانا ، مثل البروميثازين.</p><p>يرجى إخبار الطبيب أو الصيدلي إذا كنت تأخذ أو أخذت مؤخرا أي أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها دون وصفة طبية.</p><p><strong>د. تناول&nbsp; سايلومس مع الطعام و الشراب</strong></p><p>لا تشرب الكحول عند تناول هذا الدواء. وهذا لأنه يمكن ان يزيد من اثار الكحول.</p><p><strong>ه. الحمل و الرضاعه</strong></p><p><strong>الحمل</strong>:</p><p>لا ينصح باستعمال أميسولبريد خلال فترة الحمل. اذا اكتشفت حملك, استشيري الطبيب على الفور. بحيث يمكنك متابعة توصياتها بشأن علاجك. إسأل طبيبك أو الصيدلي للحصول على المشورة قبل تناول أي دواء.</p><p><strong>الرضاعة</strong>:</p><p>لا يجدر بك الارضاع في حال كنت تستعملين هذا الدواء. إسأل طبيبك أو الصيدلي للحصول على المشورة قبل تناول أي دواء.</p><p><strong>و.القيادة واستخدام الآلات</strong></p><p>يجب تنبيه سائقي السيارات و مستعملي الالات الى خطر النعاس الناتج عن استعمال أميسولبريد.</p><p><strong>ز. معلومة مهمه عن أحد مكونات&nbsp; سايلومس&nbsp;</strong></p><p>يجب عدم استعمال سايلومساذا كنت تعاني من عدم تحمل الغالاكتوز او من نقص لاكتاز لاب او من سوء امتصاص الغالاكتوز(امراض وراثية نادرة)</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>طريقة ومسار الاعطاء: للاستعمال الفموي.</p><p>لعلاج نوبات ذهانية حادة: يوصى بتناول جرعة فموية بين 400 ملغم / يوم و 800 ملغم / يوم. في حالات فردية، يمكن زيادة الجرعة اليومية لتصل إلى 1200 ملغم / يوم. لم يتم تقييم مدى سلامة جرعات فوق 1200 ملغم / يوم على نطاق واسع، وبالتالي لا ينبغي استعمالها. ليس هناك حاجة لمعايرة الجرعة عند بدء العلاج مع&nbsp; سايلومس. يجب تعديل الجرعات وفقا للاستجابة الفردية.</p><p>لعلاج المرضى الذين يعانون من أعراض إيجابية وسلبية مختلطة: يجب تعديل الجرعات للحصول على سيطرة مثلى على الأعراض الإيجابية.</p><p>العلاج الاستمراري: يجب وضعه بشكل فردي مع الجرعة الدنيا&nbsp; الفعالة.</p><p>في المرضى الذين يعانون من أعراض سلبية سائدة، ينصح بتناول جرعات عن طريق الفم بين 50 ملغم / يوم و 300 ملغم / يوم. يجب تعديل الجرعات بشكل فردي.</p><p>يمكن إعطاء&nbsp; سايلومس مرة واحدة يوميا عن طريق الفم بجرعات تصل إلى 300 ملغم، وينبغي إعطاء الجرعات الأعلى مرتين يوميا , يجب استعمال أقل جرعة فعالة.</p><p>كبار السن: ينبغي استعمال أميسولبريد بحذر شديد بسبب احتمال وجود خطر انخفاض ضغط الدم والنعس. قد يكون هناك حاجة لتخفيض الجرعة أيضا بسبب القصور الكلوي.</p><p>الأطفال: لم يتم تأكيد مدى فعالية وسلامة استعمال أميسولبريد من سن البلوغ إلى سن 18 سنوات. هناك بيانات محدودة عن استعمال أميسولبريد لدى المراهقين الذين يعانون من الفصام. لذلك، فمن غير المستحسن استعمال أميسولبريد من سن البلوغ إلى سن 18 سنة؛ يمنع استعمال أميسولبريد في الأطفال حتى سن البلوغ، كما لم يتم بعد إثبات مأمونيته.</p><p>القصور الكلوي: يتم التخلص من&nbsp; سايلومس عن الطريق الكلوي. في القصور الكلوي، يجب تقليل الجرعة إلى النصف في المرضى الذين يعانون من تصفية الكرياتينين (CRCL) بين 30-60 مل / دقيقة والى الثلث في المرضى الذين يعانون من تصفية الكرياتينين بين 10-30 مل / دقيقة. كما لا توجد خبرة في المرضى الذين يعانون من القصور الكلوي الحاد (تصفية الكرياتينين أقل من 10 مل / دقيقة) ينصح بوضع عناية خاصة في هؤلاء المرضى.</p><p>القصور الكبدي: بما أن الدواء يستقلب بشكل ضعيف فإن تخفيض الجرعة يجب أن لا يكون ضروريا.</p><p>مدة العلاج : يجب التقيد بدقة بوصفة الطبيب. يجب عدم ايقاف العلاج من تلقاء نفسك.</p><p><strong>أ. إذا تناولت &nbsp;سايلومس أكثر مما يجب</strong></p><p>اتصل بالطبيب أو المستشفى فورا. خذ الاقراص ، النشرة و/أو العلبة معك حتى يعرف الطبيب ما كنت قد تناولت. قد يحدث الآثار التالية: الشعور بالقلق أو الهشاشة ، جمود العضلات ، وانخفاض ضغط الدم ، والشعور بالنعاس أو النعاس الذي يمكن ان يؤدي إلى فقدان الوعي.</p><p><strong>ب.اذا نسيت تناول أقراص سايلومس :</strong></p><p>تناول الجرعة التالية في الوقت المعتاد. لا تتناول جرعة مضاعفة. إذا نسيت عدة جرعات, استشر الطبيب.</p><p><strong>ج. إذا توقفت عن تناول أقراص &nbsp;سايلومس</strong></p><p>في جميع الحالات ، اتبع بدقة&nbsp; وصفة الطبيب. يجب عدم ايقاف العلاج من تلقاء نفسك</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل كل الأدوية، يمكن أن يسبب&nbsp; سايلومس آثارا جانبية، وإن لم يصب بها&nbsp; كل الاشخاص.</p><p>توقف عن تناول أميسولبريد وعليك رؤية الطبيب أو الذهاب إلى المستشفى على الفور إذا لاحظت اي من الآثار الجانبية التالية:</p><p>غير شائع (قد يؤثر علي ما يصل إلى 1 في 100 شخص)</p><p>&bull; رد فعل تحسسي خطير. قد تتضمن العلامات طفحا جلديا أو حكه أو صعوبة في البلع أو التنفس أو تورما في الشفتين أو الوجه أو الحلق أو اللسان.</p><p>&bull;(نوبة) غير معروف (لا يمكن تقدير التردد من البيانات المتوفرة)</p><p>&bull;ارتفاع في درجه الحرارة ، والتعرق ، وتصلب العضلات ، وسرعه ضربات القلب ، والتنفس السريع ويشعر الخلط ، والنعاس أو تحريكها. هذه يمكن ان تكون اعراض اثار جانبيه خطيره ولكنها نادره تسمي &laquo;متلازمة الخبيثة العصبية&raquo;</p><p>&bull;معدل ضربات القلب غير عادية ، سريع جدا معدل ضربات القلب أو الم في الصدر الذي يمكن ان يؤدي إلى نوبة قلبيه أو اضطراب القلب الذي يهدد الحياة.</p><p>&bull;جلطات دموية في الاورده خاصه في الساقين (تشمل الاعراض التورم والم والاحمرار في الساق) ، والتي قد تنتقل عبر الاوعيه الدموية إلى الرئتين مما يسبب الما في الصدر وصعوبة في التنفس. إذا لاحظت اي من هذه العلامات ، اطلب المشورة الطبية فورا.</p><p>&bull;تحصل علي المزيد من التهابات من المعتاد ، مما تسبب في الحمى ، التهاب الحلق أو قرحه الفم. قد يكون هذا بسبب انخفاض في عدد ، أو عدم وجود خلايا الدم البيضاء.</p><p>&bull;الأورام النخامية الحميدة (غير السرطانية) مثل ورم البرولاكتيما.</p><p>&bull;الشعور بتوعك ، الخلط أو الضعف ، والشعور بالمرض (الغثيان) ، وفقدان الشهية ، والشعور بالانفعال. وهذا يمكن ان يكون علامات مرض يسمي متلازمة إفراز هرمون مضاد للبول غير مناسب (SIADH).</p><p>أخبر طبيبك في أقرب وقت ممكن إذا كان لديك اي من الآثار الجانبية التالية:</p><p>شائع جدا (قد يؤثر علي أكثر من 1 من كل 10 أشخاص)</p><p>&bull;ارتجاف ، تصلب العضلات أو تشنج ، حركه بطيئه ، وإنتاج اللعاب أكثر من المعتاد أو الشعور لا يهدا.</p><p>شائع (قد يؤثر علي ما يصل إلى 1 من كل 10 أشخاص)</p><p>&nbsp;&nbsp; الحركات التي لا يمكنك السيطرة عليها ، أساسا من الراس والرقبة والفك أو العينين.</p><p>غير شائع (قد يؤثر علي ما يصل إلى 1 في 100 شخص)</p><p>&nbsp;&nbsp; الحركات التي لا يمكنك السيطرة عليها ، أساسا من الوجه أو اللسان</p><p>وتشمل الآثار الجانبية الأخرى:</p><p>شائع (قد يؤثر علي ما يصل إلى 1 من كل 10 أشخاص)</p><p>&bull;صعوبة في النوم (الأرق) أو الشعور بالقلق أو المهتاج</p><p>&bull;الشعور بالنعاس أو النعاس</p><p>&bull;الإمساك ، الشعور أو المرض ، جفاف الفم</p><p>&bull;وضع علي الوزن</p><p>&bull;انخفاض ضغط الدم ، والذي قد يسبب لك ان تشعر بالدوار</p><p>&bull;زيادة مستويات الدم من البرولاكتين (بروتين) ، والتي يمكن ان ينظر اليها في اختبار ويمكن ان يسبب:</p><p>-&nbsp;&nbsp; الم الثدي أو توسيع, إنتاج غير عادية من حليب الثدي (يمكن ان تحدث هذه في النساء والرجال)</p><p>-مشاكل الحيض مثل الفترات الفائتة</p><p>-الآثار الجنسية مثل المشاكل التي تصل إلى النشوة أو صعوبة في الحصول علي أو الحفاظ علي الانتصاب</p><p>&nbsp;&nbsp; نمو غير عادي في الغدة النخامية</p><p>غير شائع (قد يؤثر علي ما يصل إلى 1 في 100 شخص)</p><p>&bull;تباطؤ نبضات القلب</p><p>&bull;ارتفاع نسبه السكر في الدم (فرط سكر)</p><p>زيادة في انزيمات الكبد ، والتي يمكن ان ينظر اليها في اختبار الدم</p><p>نادر (قد يؤثر علي ما يصل إلى 1 في 1,000 شخص)</p><p>اعراض الانسحاب بعد وقف العلاج من جرعات عاليه من أميسولبريد. وهذه قد تشمل الشعور أو المرض صعوبة في النوم ، والأرق الشديد ، وتصلب العضلات أو حركات غير طبيعيه ، أو المرض الأصلي الخاص بك قد يعود.</p><p>غير معروف (لا يمكن تقدير التردد من البيانات المتوفرة)</p><p>اعراض الانسحاب ينظر في الأطفال حديثي الولادة حيث الام قد اتخذت هذا الدواء.</p><p>مستويات مرتفعه من بعض الدهون (الشحوم الثلاثية) والكوليسترول في الدم</p><p>&nbsp;&nbsp; الارتباك</p><p>&bull;مستويات منخفضه من الصوديوم في الدم والتي يمكن ان ينظر اليها في اختبارات الدم (نقص الصوديوم في الدم).</p><p>إذا لاحظت أي آثار جانبية غير المذكورة في هذه النشرة، أو اصبحت أي من الآثار الجانبية خطيرة. يرجى إبلاغ الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>-يحفظ بعيدا عن متناول وبصر الأطفال.</p><p>-يحفظ في درجة حرارة لا تتجاوز 30&deg;م.</p><p>-لا تستخدم أقراص&nbsp; سايلومس بعد تاريخ انتهاء الصلاحية (تاريخ انتهاء الصلاحية) الذي يرد على العبوة الخارجية. يشير تاريخ انتهاء الصلاحية إلى آخر يوم من ذلك الشهر.</p><p>-لا تستخدم أقراص&nbsp; سايلومس إذا لاحظت مواصفات علامات التدهور المرئية.</p><p>-يجب عدم التخلص من الأدوية عن طريق المياه العادمة أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. ومن شأن هذه التدابير أن تساعد على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي: أميسولبريد</p><p>سايلومس 50 ملغم أقراص: كل قرص يحتوي على 50 ملغم أميسولبريد.</p><p>سايلومس 100 ملغم أقراص : كل قرص يحتوي على 100 ملغم أميسولبريد.</p><p>سايلومس 200 ملغم أقراص : كل قرص يحتوي على 200 ملغم أميسولبريد.</p><p>سايلومس 400 ملغم أقراص : كل قرص يحتوي على 400 ملغم أميسولبريد.</p><p>السوغات:</p><p>لاكتوز، صوديوم غليكولات النشا ، هايدروكسي بروبيل ميثيل سيلليلوز، ميكروكريستالاين السيلليلوز ، وماغنيسيوم ستيرات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>سايلومس 50 ملغم أقراص: قرص أبيض دائري محدب منقوشة برمز &quot;U1&quot; من جانب واحد وسهل من الجانب الآخر. سايلومس 100 ملغم أقراص : قرص أبيض دائري محدب منقوشة برمز &quot;2U&quot; من جانب واحد وسهل من الجانب الآخر. سايلومس 200 ملغم أقراص : قرص أبيض دائري محدب منقوشة برمز &quot;3U&quot; من جانب واحد وسهل من الجانب الآخر. سايلومس 400 ملغم أقراص: قرص على شكل قلب أبيض منقوشة برمز &quot;7U&quot; من جانب واحد وسهل من الجانب الآخر. أقراص سايلومس معبأة في أشرطة من الألومنيوم/PVC/ PVDCفي علبة كرتون مع نشرة مطوية ، في عبوات حجم 30 قرص. عبوات المستشفيات متوفرة أيضاً.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>إم إس فارما السعودية الرياض ، المملكة العربية السعودية .</p><p>&nbsp;info-ksa@mspharma.com</p><p>صنعت بواسطة :&nbsp;&nbsp;</p><p>المتحدة للصناعات الدوائية - الأردن لصالح إم إس فارما &ndash; المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم الموافقة على هذه النشرة بتاريخ فبراير/2020؛
رقم النسخة : SPM190330

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Silomes®100mg Tablets 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                %(w/w) 	Amount (mg)/one tablet 	Function 	Material Name 
57.1			100.0*	Active Material 	Amisulpride
18.6	32.55	Diluent	Lactose Regular
5.0	8.75	Disintegrant	Sodium Starch Glycolate
2.0	3.50	Binder	Hydroxypropyl Methyl Cellulose
15.8	27.575*	Diluent	Microcrystalline Cellulose
1.5	2.625	Lubricant	Magnesium Stearate
----	175	Total 

*Actual quantity depends on the potency and water content of the API.

For a full list of excipients, see section 6.1 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablets 
Silomes®100mg Tablets: White round convex tablet embossed with U2 from one side plain from the other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Silomes<sup> &reg;</sup> </strong>is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, and thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Route of administration: Orally.</strong></p><p>For acute psychotic episodes, oral doses between 400 mg/d and 800 mg/d are recommended. In individual cases, the daily dose may be increased up to 1200 mg/d. Doses above 1200 mg/d have not been extensively evaluated for safety and therefore should not be used. No specific titration is required when initiating the treatment with <strong>Silomes<sup> &reg;</sup></strong>. Doses should be adjusted according to individual response.</p><p>For patients with mixed positive and negative symptoms, doses should be adjusted to obtain optimal control of positive symptoms.</p><p>Maintenance treatment should be established individually with the minimally effective dose.</p><p>For patients characterised by predominant negative symptoms, oral doses between 50 mg/d and 300 mg/d are recommended. Doses should be adjusted individually.</p><p><strong>Silomes<sup> &reg;</sup> </strong>can be administered once daily at oral doses up to 300 mg, higher doses should be administered bid.</p><p>The minimum effective dose should be used.</p><p>Elderly: The safety of amisulpride has been examined in a limited number of elderly patients. Amisulpride should be used with particular caution because of a possible risk of hypotension and sedation. Reduction in dosage may also be required because of renal insufficiency.</p><p>Children: The efficacy and safety of amisulpride from puberty to the age of 18 years have not been established. There are limited data available on the use of amisulpride in adolescents in schizophrenia. Therefore, the use of amisulpride from puberty to the age of 18 years is not recommended; in children up to puberty amisulpride is contraindicated, as its safety has not yet been established.</p><p>Renal insufficiency: <strong>Silomes<sup> &reg;</sup> </strong>is eliminated by the renal route. In renal insufficiency, the dose should be reduced to half in patients with creatinine clearance (CR<sub>CL</sub>) between 30-60 ml/min and to a third in patients with CR<sub>CL</sub>&nbsp;between 10-30 ml/min. As there is no experience in patients with severe renal impairment (CR<sub>CL</sub>&nbsp;&lt; 10 ml/min) particular care is recommended in these patients.</p><p>Hepatic insufficiency: since the drug is weakly metabolised a dosage reduction should not be necessary.</p><p><em>Duration of treatment</em></p><p>Data from controlled clinical trials covering a period of 1 year is available. The duration of treatment should be determined by the treating physician.</p><p>To avoid withdrawal symptoms treatment should be discontinued gradually (see section 4.4).</p><p><u>Method of administration</u></p><p>For oral use.</p><p>Tablets should be swallowed whole or halved, with a sufficient amount of liquid. Amisulpride can be administered independently from meals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                -	Hypersensitivity to the active ingredient or to other ingredients of the medicinal product
-	Concomitant prolactin-dependent tumours (e.g. pituitary gland prolactinomas or breast cancer)
-	Phaeochromocytoma
-	Children before the onset of puberty
-	Lactation
-	Combination with levodopa 
-	In combination with the following medicinal products which could induce torsade de pointes:
-	class Ia antiarrhythmics such as quinidine and disopyramide
-	class III antiarrhythmics such as amiodarone and sotalol
-	other medicinal products such as bepridil, cisapride, sultopride, thioridazine, methadone, erythromycin (intravenous application), vincamine (intravenous application), halofantrine, pentamidine, sparfloxacin, azole antifungals

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As with other neuroleptics, Neuroleptic Malignant Syndrome, a potentially fatal complication, characterized by hyperthermia, muscle rigidity, autonomic instability, altered consciousness and elevated CPK, may occur. In the event of hyperthermia, particularly with high daily doses, all antipsychotic drugs including Amisulpride should be discontinued.</p><p>Hyperglycaemia has been reported in patients treated with some atypical antipsychotic agents, including amisulpride, therefore patients with an established diagnosis of diabetes mellitus or with risk factors for diabetes who are started on amisulpride, should get appropriate glycaemic monitoring.</p><p>Amisulpride is eliminated by the renal route. In cases of renal insufficiency, the dose should be decreased or intermittent treatment could be considered.</p><p>Amisulpride may lower the seizure threshold. Therefore patients with a history of epilepsy should be closely monitored during Amisulpride therapy.</p><p>In elderly patients, Amisulpride, like other neuroleptics, should be used with particular caution because of a possible risk of hypotension or sedation. Reduction in dosage may also be required because of renal insufficiency.</p><p>As with other antidopaminergic agents, caution should be also exercised when prescribing Amisulpride to patients with Parkinson&#39;s disease since it may cause worsening of the disease. Amisulpride should be used only if neuroleptic treatment cannot be avoided.</p><p>Acute withdrawal symptoms including nausea, vomiting and insomnia have very rarely been described after abrupt cessation of high doses of antipsychotic drugs. Recurrence of psychotic symptoms may also occur, and the emergence of involuntary movement disorders (such as akathisia, dystonia and dyskinesia) has been reported. Therefore, gradual withdrawal of amisulpride is advisable.</p><p><u>Prolongation of the QT interval</u></p><p>Amisulpride induces a dose-dependent prolongation of the QT interval. This effect is known to potentiate the risk of serious ventricular arrhythmias such as torsade de pointes. Before any administration, and if possible according to the patient&#39;s clinical status, it is recommended to exclude the following factors which could favour the occurrence of this rhythm disorder:</p><p>&bull; bradycardia less than 55 bpm</p><p>&bull; cardiac disease or family history of sudden death or QT prolongation</p><p>&bull; electrolyte imbalance, in particular hypokalaemia</p><p>&bull; congenital prolongation of the QT interval</p><p>&bull; on-going treatment with a medicinal product likely to produce pronounced bradycardia (&lt; 55 bpm), hypokalaemia, decreased intracardiac conduction, or prolongation of the QT interval.</p><p>Baseline ECG is recommended prior to treatment in all patients especially in the elderly and patients with a positive personal or family history of cardiac disease or abnormal findings on cardiac clinical examination. During therapy, the need for ECG monitoring (e.g. at dose escalation) should be assessed on an individual patient basis. The dose of amisulpride should be reduced if QT is prolonged and discontinued if QTc is &gt;500ms.</p><p>Periodic electrolyte monitoring is recommended particularly if the patient is taking diuretics or during inter-current illness.</p><p>Concomitant use with antipsychotics should be avoided.</p><p>Stroke:</p><p>In elderly patients with dementia and treated with certain atypical antipsychotic drugs, a 3-fold increase of the risk of cerebrovascular events has been observed. The mechanism of such risk increase is not known. An increase in the risk with other antipsychotic drugs, or other populations of patients cannot be excluded. Amisulpride should be used with caution in patients with stroke risk factors.</p><p>Elderly patients with dementia:</p><p>Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. The extent to which the findings of increased mortality may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear.</p><p>Amisulpride is not licensed for the treatment of dementia-related behavioural disturbances.</p><p>Venous thromboembolism:</p><p>Cases of venous thromboembolism (VTE) have been reported with antipsychotic drugs. Since patients treated with antipsychotics often present with acquired risk factors for VTE, all possible risk factors for VTE should be identified before and during treatment with Amisulpride and preventive measures undertaken.</p><p>Breast cancer:</p><p>Amisulpride may increase prolactin levels. Therefore, caution should be exercised and patients with a history or a family history of breast cancer should be closely monitored during Amisulpride therapy.</p><p>Benign pituitary tumour:</p><p>Amisulpride may increase prolactin levels. Cases of benign pituitary tumours such as prolactinoma have been observed during amisulpride therapy. In case of very high levels of prolactin or clinical signs of pituitary tumour (such as visual field defect and headache), pituitary imaging should be performed. If the diagnosis of pituitary tumour is confirmed, the treatment with amisulpride must be stopped.</p><p>Leukopenia, neutropenia and agranulocytosis have been reported with antipsychotics, including Amisulpride. Unexplained infections or fever may be evidence of blood dyscrasia, and requires immediate haematological investigation.</p><p>Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Contraindicated combinations:</u></p><p>&bull; Medicinal products which could induce torsade de pointes:</p><p>o class Ia antiarrhythmics such as quinidine and disopyramide</p><p>o class III antiarrhythmics such as amiodarone and sotalol</p><p>o other medicinal products such as bepridil, cisapride, sultopride, thioridazine, methadone, erythromycin (intravenous application), vincamine (intravenous application), halofantrine, pentamidine, sparfloxacin, azole antifungals.</p><p>&bull; Levodopa: reciprocal antagonism of effects between levodopa and neuroleptics. Amisulpride may oppose the effect of dopamine agonists e.g. bromocriptine, ropinirole.</p><p><u>Combinations not recommended:</u></p><p>&bull; Medicinal products which enhance the risk of torsade de pointes or could prolong the QT interval:</p><p>o bradycardia-inducing medicinal products such as beta-blockers, bradycardia-inducing calcium channel blockers such as diltiazem and verapamil, clonidine, guanfacine; and digitalis</p><p>o medicinal products which induce hypokalaemia or electrolyte imbalance: hypokalemic diuretics, stimulant laxatives, amphotericin B (intravenous application), glucocorticoids, and tetracosactides. Hypokalaemia should be corrected.</p><p>o antipsychotics such as pimozide, and haloperidol</p><p>o imipramine antidepressants</p><p>o lithium</p><p>o some antihistamines such as astemizole, and terfenadine</p><p>o mefloquine</p><p>&bull; Amisulpride may enhance the effects of alcohol. Therefore alcohol should not be consumed during treatment.</p><p><u>Combinations which require precautions for use:</u></p><p>Concomitant use of the following agents can lead to potentiation of the effect:</p><p>&bull; CNS depressants including narcotics, anaesthetics, analgesics, sedative H<sub>1</sub> antihistamines, barbiturates, benzodiazepines and other anxiolytics, clonidine and derivatives.</p><p>&bull; Antihypertensive drugs and other hypotensive medications.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>In animals, Amisulpride did not show reproductive toxicity. A decrease in fertility linked to the pharmacological effects of the drug (prolactin mediated effect) was observed. No teratogenic effects of Amisulpride were noted.</p><p>Very limited clinical data on exposed pregnancies are available. Therefore, the safety of Amisulpride during human pregnancy has not been established.</p><p>Use of the drug is not recommended during pregnancy unless the benefits justify the potential risks.</p><p>For women of childbearing potential, effective contraception should be fully discussed with the physician prior to treatment.</p><p>Neonates exposed to antipsychotics (including Amisulpride) during the third trimester of pregnancy are at risk of adverse reactions including extrapyramidal and/or withdrawal symptoms that may vary in severity and duration following delivery. There have been reports of agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress, or feeding disorder. Consequently, newborns should be monitored carefully.</p><p><strong>Lactation</strong></p><p>It is not known whether Amisulpride is excreted in breast milk, breast-feeding is therefore contra-indicated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Even used as recommended, Amisulpride may cause somnolence and blurred vision so that the ability to drive vehicles or operate machinery can be impaired.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Adverse effects have been ranked under headings of frequency using the following convention: very common (</em>&ge;<em>1/10); common (</em>&ge;<em>1/100; &lt;1/10); uncommon (</em>&ge;<em>1/1,000;&lt;1/100); rare (</em>&ge;<em>1/10,000;&lt;1/1,000); very rare (&lt;1/10,000); frequency not known (cannot be estimated from the available data).</em></p><p>It should be noted that in some instances it can be difficult to differentiate adverse events from symptoms of the underlying disease.</p><p><u>&bull; Nervous system disorders:</u></p><p><em>Very common:&nbsp;</em>Extrapyramidal symptoms may occur: tremor, rigidity, hypokinesia, hypersalivation, akathisia, and dyskinesia. These symptoms are generally mild at optimal dosages and partially reversible without discontinuation of amisulpride upon administration of antiparkinsonian medication. The incidence of extrapyramidal symptoms which is dose related, remains very low in the treatment of patients with predominantly negative symptoms with doses of 50-300 mg/day.</p><p><em>Common:&nbsp;</em>Acute dystonia (spasm torticollis, oculogyric crisis, and trismus) may appear. This is reversible without discontinuation of amisulpride upon treatment with an antiparkinsonian agent. Somnolence.</p><p><em>Uncommon:&nbsp;</em>Tardive dyskinesia characterized by rhythmic, involuntary movements primarily of the tongue and/or face have been reported, usually after long term administration.</p><p>Antiparkinsonian medication is ineffective or may induce aggravation of the symptoms. Seizures.</p><p><u>&bull; Psychiatric disorders:</u></p><p><em>Common</em>: Insomnia, anxiety, agitation, orgasmic dysfunction</p><p><u>&bull; Gastrointestinal disorders</u></p><p><em>Common:&nbsp;</em>Constipation, nausea, vomiting, dry mouth</p><p><u>&bull; Endocrine disorders:</u></p><p><em>Common:&nbsp;</em>Amisulpride causes an increase in plasma prolactin levels which is reversible after drug discontinuation. This may result in galactorrhoea, amenorrhoea, gynaecomastia, breast pain, and erectile dysfunction.</p><p>&bull;&nbsp;<u>Metabolism and nutrition disorders</u></p><p><em>Uncommon:&nbsp;</em>Hyperglycemia.</p><p><u>&bull; Cardiovascular disorders</u></p><p><em>Common:&nbsp;</em>Hypotension</p><p><em>Uncommon:&nbsp;</em>Bradycardia</p><p>&bull;&nbsp;<u>Investigations:</u></p><p><em>Common:&nbsp;</em>Weight gain</p><p><em>Uncommon:&nbsp;</em>Elevations of hepatic enzymes, mainly transaminases</p><p><u>&bull; Immune system disorders</u></p><p><em>Uncommon:&nbsp;</em>Allergic reaction</p><p>In addition, cases of the following adverse reactions have been reported through spontaneous reporting only:</p><p>&bull;&nbsp;<u>Blood and Lymphatic system disorders:</u></p><p><em>Frequency not known:&nbsp;</em>Leukopenia, neutropenia and agranulocytosis</p><p>&bull;&nbsp;<u>Endocrine disorders:</u></p><p><em>Frequency not known:</em>&nbsp;Benign pituitary tumour such as prolactinoma</p><p>&bull;&nbsp;<u>Metabolism and nutrition disorders:</u></p><p><em>Frequency not known:</em>&nbsp;hypertriglyceridemia and hypercholesterolemia. Hyponatraemia, syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p><p>&bull;&nbsp;<u>Psychiatric disorders:</u></p><p><em>Frequency not known:</em>&nbsp;confusion</p><p>&bull;&nbsp;<u>Nervous system disorders:</u></p><p><em>Frequency not known:&nbsp;</em>Neuroleptic Malignant Syndrome, which is a potentially fatal complication</p><p>&bull;&nbsp;<u>Eye disorders:</u></p><p><em>Frequency not known:</em>&nbsp;Blurred vision.</p><p>&bull;&nbsp;<u>Cardiac disorders:</u></p><p><em>Frequency not known:&nbsp;</em>QT interval prolongation and ventricular arrhythmias such as torsade de pointes, ventricular tachycardia, which may result in ventricular fibrillation or cardiac arrest, sudden death.</p><p>&bull;&nbsp;<u>Vascular disorders:</u></p><p><em>Frequency not known:&nbsp;</em>Cases of venous thromboembolism, including cases of pulmonary embolism, sometimes fatal, and cases of deep vein thrombosis have been reported with antipsychotic drugs.</p><p>&bull;&nbsp;<u>Skin and subcutaneous tissue disorders:</u></p><p><em>Frequency not known:&nbsp;</em>Angioedema, urticaria</p><p>&bull;&nbsp;<u>Musculoskeletal and connective tissue disorders:</u></p><p><em>Frequency not known:</em>&nbsp;Osteopenia, osteoporosis</p><p>&bull;&nbsp;<u>Pregnancy, puerperium and perinatal conditions:</u></p><p><em>Frequency not known:&nbsp;</em>Drug withdrawal syndrome neonatal</p><p>&bull;&nbsp;<u>Respiratory, thoracic and mediastinal disorders:</u></p><p><em>Frequency not known:</em>&nbsp;Nasal congestion</p><p><strong>&nbsp;</strong></p><p><strong>To report any side effect(s): </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia: </strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>National Pharmacovigilance &amp; Drug Safety Centre (NPC):</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call NPC at +966-11-2038222, Ext.: 2317-2356-2353-2354-2334-2340.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Toll free phone : 8002490000</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: <strong>npc.drug@sfda.gov.sa</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: www.sfda.gov.sa/npc</p></td></tr></tbody></table><p>-&nbsp;&nbsp; <strong>Other GCC States: </strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p>Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Experience with Amisulpride in overdosage is limited. Exaggeration of the known pharmacological effects of the drug have been reported. These include drowsiness and sedation, coma, hypotension and extrapyramidal symptoms. Fatal outcomes have been reported mainly in combination with other psychotropic agents.</p><p>In cases of acute overdosage, the possibility of multiple drug intake should be considered.</p><p>Since Amisulpride is weakly dialysed, hemodialysis is of no use to eliminate the drug.</p><p>There is no specific antidote to Amisulpride.</p><p>Appropriate supportive measures should therefore be instituted with close supervision of vital functions including continuous cardiac monitoring due to the risk of prolongation of the QT interval until the patient recovers.</p><p>If severe extrapyramidal symptoms occur, anticholinergic agents should be administered.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group:</strong> Antipsychotics</p><p><strong>ATC Code:</strong> NO5A LO5</p><p>Amisulpride binds selectively with a high affinity to human dopaminergic D<sub>2</sub>/D<sub>3</sub>&nbsp;receptor subtypes whereas it is devoid of affinity for D<sub>1</sub>, D<sub>4</sub>&nbsp;and D<sub>5</sub>&nbsp;receptor subtypes.</p><p>Unlike classical and atypical neuroleptics, amisulpride has no affinity for serotonin,&nbsp;<!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="Picture_x0020_3" o:spid="_x0000_i1025" type="#_x0000_t75"
 alt="PROPORTIONAL TO (8733)" style='width:9pt;height:9pt;visibility:visible'>
 <v:imagedata src="file:///C:/Users/DELL/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif"
  o:title="PROPORTIONAL TO (8733)"/>
</v:shape><![endif]--><img width="12" height="12" alt="PROPORTIONAL TO (8733)" src="file:///C:/Users/DELL/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" />-adrenergic, histamine H<sub>1</sub>&nbsp;and cholinergic receptors. In addition, amisulpride does not bind to sigma sites. At low doses it preferentially blocks pre-synaptic D<sub>2</sub>/D<sub>3</sub>&nbsp;receptors, producing dopamine release responsible for its disinhibitory effects.</p><p>This pharmacological profile explains the clinical efficacy of Amisulpride against both negative and positive symptoms of schizophrenia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In man, amisulpride shows two absorption peaks: one which is attained rapidly, one hour post-dose and a second between 3 and 4 hours after administration. Corresponding plasma concentrations are 39 &plusmn; 3 and 54 &plusmn; 4 ng/ml after a 50 mg dose.</p><p>The volume of distribution is 5.8 l/kg, plasma protein binding is low (16%) and no drug interactions are suspected.</p><p>Absolute bioavailability is 48%. Amisulpride is weakly metabolised: two inactive metabolites, accounting for approximately 4% of the dose, have been identified. There is no accumulation of amisulpride and its pharmacokinetics remain unchanged after the administration of repeated doses. The elimination half-life of amisulpride is approximately 12 hours after an oral dose.</p><p>Amisulpride is eliminated unchanged in the urine. Fifty percent of an intravenous dose is excreted via the urine, of which 90% is eliminated in the first 24 hours. Renal clearance is in the order of 20 l/h or 330 ml/min.</p><p>A carbohydrate rich meal (containing 68% fluids) significantly decreases the AUCs, Tmax and Cmax of amisulpride but no changes were seen after a high fat meal. However, the significance of these findings in routine clinical use is not known.</p><p>Hepatic insufficiency: since the drug is weakly metabolised a dosage reduction should not be necessary in patients with hepatic insufficiency.</p><p>Renal insufficiency: The elimination half-life is unchanged in patients with renal insufficiency while systemic clearance is reduced by a factor of 2.5 to 3. The AUC of amisulpride in mild renal failure increased two fold and almost tenfold in moderate renal failure. Experience is however limited and there is no data with doses greater than 50 mg.</p><p>Amisulpride is very weakly dialysed.</p><p>Limited pharmacokinetic data in elderly (&gt; 65 years) show that a 10-30 % rise occurs in Cmax, T1/2 and AUC after a single oral dose of 50 mg. No data are available after repeat dosing.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>An overall review indicates that Amisulpride is devoid of any general, organ-specific, teratogenic, mutagenic or carcinogenic risk. Compared with the maximum recommended dosages in man, maximum tolerated doses are 2 and 7 times greater. No carcinogenic risk, relevant to man, was identified.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td><p>Lactose Regular</p></td></tr><tr><td><p>Sodium Starch Glycolate</p></td></tr><tr><td><p>Hydroxypropyl Methyl Cellulose</p></td></tr><tr><td><p>Microcrystalline Cellulose</p></td></tr><tr><td><p>Magnesium Stearate</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Silomes&reg;100mg Tablets are packed in Aluminum foil, PVC coated with PVDC blisters, with a multi folded leaflet packed in registration box.Pack sizes:30 tablets (10 tablets / blister, 3 blisters/ pack)</p><p>Hospital packs are also available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Any unused product or waste should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MS Pharma-Saudi  King Abdulaziz road - Alrabea District Grand Center 1st floor – Front of Kingdom Hospital P.O Box 47315 Riyadh, 13456 Saudi Arabia Phone: + 966112790122     Ext. 200 Fax: +966112471323 E-mail: Albaraa.bahhari@mspharma.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                08/2016 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>